Summary of Study ST002285

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001465. The data can be accessed directly via it's Project DOI: 10.21228/M8C12D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002285
Study TitleMultiplatform mass spectrometry-based analysis of Leishmania donovani infected macrophages at different time points after infection
Study TypeMutiplatform mass spectrometry-based metabolomics, time course experiment
Study SummaryThe project aims to measure targeted and non-targeted metabolite data of intracellular extracts of uninfected and Leishmania-donovani infected macrophages at 0, 12, 36 and 72 hours post infection using a multiplatform mass spectrometry approach combining CE-TOF/MS (polar metabolites), LC-QTOF/MS (non-polar metabolites) and LC-QqQ/MS (polar metabolites) to characterize the dynamics of metabolic alterations ocurring in the human macrophage upon L. donovani infection.
Institute
Universidad CEU San Pablo
DepartmentChemistry and Biochemistry
LaboratoryCentre for Metabolomics and Bioanalysis (CEMBIO)
Last NameFernández García
First NameMiguel
AddressCentro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte. España
Emailmig.fernandez.ce@ceindo.ceu.es
Phone+0034690090778
Submit Date2022-07-01
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2024-07-01
Release Version1
Miguel Fernández García Miguel Fernández García
https://dx.doi.org/10.21228/M8C12D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN003734 AN003735 AN003736 AN003737
Analysis type MS MS MS MS
Chromatography type CE Reversed phase Reversed phase Reversed phase
Chromatography system Agilent 7100 CE Agilent 1200 Agilent 1200 Agilent 1290 Infinity
Column bare-fused silica capillary (96 cm,50um),Agilent Technologies Agilent Zorbax Extend C18 RRHT (50 x 2.1mm,1.8 um) Agilent Zorbax Extend C18 RRHT (50 x 2.1mm,1.8 um) Agilent Zorbax RRHD SB-C18 (100 x 2.1mm,1.8um)
MS Type ESI ESI ESI ESI
MS instrument type TOF QTOF QTOF Triple quadrupole
MS instrument name Agilent 6224 TOF Agilent 6545 QTOF Agilent 6545 QTOF Agilent 6460 QQQ
Ion Mode POSITIVE POSITIVE NEGATIVE NEGATIVE
Units Abundances Abundances Abundances Normalized abundances

Chromatography:

Chromatography ID:CH002766
Chromatography Summary:CE separation for charged metabolites which ionice in positive mode, in acid media.
Instrument Name:Agilent 7100 CE
Column Name:bare-fused silica capillary (96 cm,50um),Agilent Technologies
Column Temperature:20 ºC
Injection Temperature:20 ºC
Internal Standard:methionine sulfone
Sample Injection:50 mbar for 100 s hydrodynamical injection stacking of 100 mbar for 20 s
Capillary Voltage:30 kV
Running Buffer:1M formic acid in MeOH:H2O 1:9 (v/v)
Sheath Liquid:100 mL of Milli-Q water with 100 mL of 100% methanol (Thermo Fisher Scientific, Loughborough, UK), 4 µL of concentrated formic acid, 10 µL of 5 mM purine and 10 µL 2.5 hexakis (1H,1H,3H-tetrafluoropropoxy)phosphazene HP722 (CE-TOF/MS reference masses, Agilent Technologies, CA, USA)
Chromatography Type:CE
  
Chromatography ID:CH002767
Chromatography Summary:RPLC method for separating phospholipids and non very non-polar lipids
Instrument Name:Agilent 1200
Column Name:Agilent Zorbax Extend C18 RRHT (50 x 2.1mm,1.8 um)
Column Temperature:60 ºC
Flow Gradient:Initial conditions at time 0 were 5% B, held until 1 min. Next, the percentage of organic phase was gradually increased up to 80% B at 7 min and subsequently until 100% B at 11.5 min. The conditions were then returned to the starting conditions by 12 min, followed by a 3 min re-equilibration time. The total run time of the method was 15 min.
Flow Rate:0.6 mL/min
Injection Temperature:4 ºC
Sample Injection:8 uL
Solvent A:100% water; 0.1% formic acid
Solvent B:100% acetonitrile; 0.1% formic acid
Chromatography Type:Reversed phase
  
Chromatography ID:CH002768
Chromatography Summary:Adapted from Agilent dMRM database and method with minor modifications
Instrument Name:Agilent 1290 Infinity
Column Name:Agilent Zorbax RRHD SB-C18 (100 x 2.1mm,1.8um)
Column Temperature:35 ºC
Flow Gradient:Binary pump gradient: Time (min) flow (mL/min) %B; Quaternary pump gradient: Time (min) flow (mL/min) %C %D 0 0 1 99 23.95 0 1 99 24 0.2 1 99 27 0.2 1 99 27.5 0.3 1 99 43.35 0.3 1 99 43.5 0.3 1 99 52.25 0.2 100 0 59 0.2 100 0 59.9 0.2 1 99 60 0 1 99 0.00 0.25 0 2.5 0.25 0 7.5 0.25 20 13 0.25 45 20 0.25 99 24 0.25 99 24.05 0 99 24.1 0 0 58.95 0 0 59 0.20 0 60 0.25 0;
Flow Rate:0.25 mL/min
Injection Temperature:4 ºC
Sample Injection:20 uL
Solvent A:97% water/3% methanol; 15 mM acetic acid; 10 mM tributylamine
Solvent B:100% methanol; 15 mM acetic acid; 10 mM tributylamine;
Chromatography Type:Reversed phase
  logo